TY - JOUR
T1 - Structural abnormalities in islets from very young children with cystic fibrosis may contribute to cystic fibrosis-related diabetes
AU - Bogdani, Marika
AU - Blackman, Scott M.
AU - Ridaura, Cecilia
AU - Bellocq, Jean Pierre
AU - Powers, Alvin C.
AU - Aguilar-Bryan, Lydia
N1 - Funding Information:
This work was supported by NIH-NIDDK grant to LA-B (R01DK097829). The authors thank Dr. Stanislaw Sadowinski, Hospital Infantil de Mexico Federico Gomez, Mexico City, Dr. Chanjuan Shi, Department of Pathology, Vanderbilt University Medical Center, Nashville, TN, for providing pancreas tissues from control and CF subjects, and the University of Washington DRC, Cellular and Molecular Imaging Core (P30 DK017047). We thank the Network for Pancreatic Organ Donors with Diabetes (nPOD), a collaborative type 1 diabetes research project sponsored by JDRF, for providing pancreas tissues from control and CFRD donors. Organ Procurement Organizations (OPO) partnering with nPOD to provide research resources are listed at http://www.jdrfnpod.org/ for-partners/npod-partners/.
Publisher Copyright:
© 2017 The Author(s).
PY - 2017/12/1
Y1 - 2017/12/1
N2 - Cystic fibrosis (CF)-related diabetes (CFRD) is thought to result from beta-cell injury due in part to pancreas exocrine damage and lipofibrosis. CFRD pancreata exhibit reduced islet density and altered cellular composition. To investigate a possible etiology, we tested the hypothesis that such changes are present in CF pancreata before the development of lipofibrosis. We evaluated pancreas and islet morphology in tissues from very young CF children (<4 years of age), and adult patients with CF and CFRD. The relative number of beta-cells in young CF tissues was reduced by 50% or more when compared to age-matched controls. Furthermore, young CF tissues displayed significantly smaller insulin-positive areas, lower proportion of beta-cells positive for the proliferation marker Ki67 or the ductal marker CK19 vs. control subjects, and islet inflammatory cell infiltrates, independently of the severity of the exocrine lesion and in the absence of amyloid deposits. CFRD pancreata exhibited greater islet injury with further reduction in islet density, decreased relative beta-cell number, and presence of amyloid deposits. Together, these results strongly suggest that an early deficiency in beta-cell number in infants with CF may contribute to the development of glucose intolerance in the CF pediatric population, and to CFRD, later in life.
AB - Cystic fibrosis (CF)-related diabetes (CFRD) is thought to result from beta-cell injury due in part to pancreas exocrine damage and lipofibrosis. CFRD pancreata exhibit reduced islet density and altered cellular composition. To investigate a possible etiology, we tested the hypothesis that such changes are present in CF pancreata before the development of lipofibrosis. We evaluated pancreas and islet morphology in tissues from very young CF children (<4 years of age), and adult patients with CF and CFRD. The relative number of beta-cells in young CF tissues was reduced by 50% or more when compared to age-matched controls. Furthermore, young CF tissues displayed significantly smaller insulin-positive areas, lower proportion of beta-cells positive for the proliferation marker Ki67 or the ductal marker CK19 vs. control subjects, and islet inflammatory cell infiltrates, independently of the severity of the exocrine lesion and in the absence of amyloid deposits. CFRD pancreata exhibited greater islet injury with further reduction in islet density, decreased relative beta-cell number, and presence of amyloid deposits. Together, these results strongly suggest that an early deficiency in beta-cell number in infants with CF may contribute to the development of glucose intolerance in the CF pediatric population, and to CFRD, later in life.
UR - http://www.scopus.com/inward/record.url?scp=85037671173&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85037671173&partnerID=8YFLogxK
U2 - 10.1038/s41598-017-17404-z
DO - 10.1038/s41598-017-17404-z
M3 - Article
C2 - 29222447
AN - SCOPUS:85037671173
SN - 2045-2322
VL - 7
JO - Scientific reports
JF - Scientific reports
IS - 1
M1 - 17231
ER -